FDA-approved indications for bevacizumab (Avastin) include: Metastatic colorectal cancer (mCRC), first- and second-line Non-squamous non-small cell lung cancer (NSCLC), first-line Glioblastoma (GBM), recurrent Metastatic renal cell carcinoma (mRCC) Persistent, recurrent, or metastatic cervical cancer Platinum-resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer Platinum-sensitive recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer Hepatocellular carcinoma (HCC), unresectable Endometrial carcinoma (certain combinations) Colorectal cancer, the most common bevacizumab indication, is typically confirmed through a diagnostic colonoscopy such as 45378 before staging establishes metastatic disease and bevacizumab therapy begins
Diarrhea is frequent, watery stoolsoften from infection or intoleranceusually short-term but sometimes serious
Both peptides are widely used in research contexts under appropriate regulatory oversight
In recent years, the supplement industry has grabbed onto this term to describe products with vitamins, minerals, amino acids, and botanicals that are designed to boost your brain power
Therefore, seek the guidance of a medical professional before obtaining a B12 shot
